Balyasny Asset Management
TRVI icon

Balyasny Asset Management’s Trevi Therapeutics TRVI Stock Holding History

Balyasny Asset Management’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$12.9M Buy
2,354,402
+595,783
+34% +$3.26M 0.02% 627
2025
Q1 		$11.1M Buy
+1,758,619
New +$11.1M 0.02% 618